Literature DB >> 305467

Time course of clinical and physiological effects of stimulation of the cerebellar surface in patients with spasticity.

D L McLellan, M Selwyn, I S Cooper.   

Abstract

A double-blind study of the short-term (12--48 hours) effects of cerebellar stimulation was performed on 11 selected patients with spasticity. Six of patients had a good clinical long-term response to chronic stimulation, four had a moderate response, and one had no response. Each patient received stimulation for two periods of 24 hours and was off stimulation for two periods of 24 hours. The periods were randomised over four consecutive days. Neither the patients nor the observer could distinguish between the days on stimulation and the days off stimulation. Simple tests of function of the upper limbs during stimulation, measurements of H responses, tonic vibration responses, vibration-induced suppression of H responses, stretch responses, and co-contraction, showed no differences between the four days. These results are contrasted with acute physiological changes seen in some patients during stimulation and also with the slow progressive improvement in clinical function that characterises the successful clinical response. It is suggested that lack of either acute or short-term changes in response to cerebellar stimulation does not predict the clinical outcome. If the strength of stimulation is changed, at least three days and preferably 10 days should be allowed for the effects to appear. The mechanisms responsible for the alleviation of spasticity are likely to be more complex than those mediating acute and reversible changes in reflex activity.

Entities:  

Mesh:

Year:  1978        PMID: 305467      PMCID: PMC492983          DOI: 10.1136/jnnp.41.2.150

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Chronic cerebellar stimulation in cerebral palsy.

Authors:  I S Cooper; M Riklan; I Amin; J M Waltz; T Cullinan
Journal:  Neurology       Date:  1976-08       Impact factor: 9.910

2.  Chronic cerebellar stimulation and developmental reflexes.

Authors:  R D Penn; M L Etzel
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

3.  Effect of baclofen upon monosynaptic and tonic vibration reflexes in patients with spasticity.

Authors:  D L Mclellan; D L Maclellan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

4.  The reflex response to sinusoidal stretching in spastic man.

Authors:  D Burke; C J Andrews; J D Gillies
Journal:  Brain       Date:  1971       Impact factor: 13.501

5.  Some neurophysiological effects of cerebellar stimulation in man.

Authors:  A R Upton; I S Cooper
Journal:  Can J Neurol Sci       Date:  1976-11       Impact factor: 2.104

6.  Activation of neurons in the cerebellar nuclei and ascending reticular formation by stimulation of the cerebellar surface.

Authors:  H Bantli; J R Bloedel; D Tolbert
Journal:  J Neurosurg       Date:  1976-11       Impact factor: 5.115

7.  Cerebrospinal fluid GABA reductions in seizure patients evoked by cerebellar surface stimulation.

Authors:  J H Wood; B S Glaeser; T A Hare; J Sode; B R Brooks; J M Van Buren
Journal:  J Neurosurg       Date:  1977-10       Impact factor: 5.115

8.  Cerebrospinal fluid norepinephrine alterations during electrical stimulation of cerebellar, cerebral surfaces in epileptic patients.

Authors:  J H Wood; C R Lake; M G Ziegler; J Sode; B R Brooks; J M Van Buren
Journal:  Neurology       Date:  1977-08       Impact factor: 9.910

9.  C0-contraction and stretch reflexes in spasticity during treatment with baclofen.

Authors:  D L McLellan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-01       Impact factor: 10.154

  9 in total
  9 in total

1.  Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.

Authors:  G Ochs; A Struppler; B A Meyerson; B Linderoth; J Gybels; B P Gardner; P Teddy; A Jamous; P Weinmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

2.  The effect of intrathecal baclofen on electrical muscle activity in spasticity.

Authors:  H Müller; J Zierski; D Dralle; U Börner; O Hoffmann
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

3.  Calibration of clinical cerebellar and deep brain stimulation systems.

Authors:  D L McLellan; G D Wright; F Renouf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

4.  Changing patterns of communicable disease in England and Wales. Part III--Increasing infectious diseases.

Authors:  N S Galbraith; P Forbes; R T Mayon-White
Journal:  Br Med J       Date:  1980-08-23

5.  Pathophysiological mechanisms in cerebral palsy.

Authors:  H S Milner-Brown; R D Penn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-07       Impact factor: 10.154

6.  A comparative study of methods for estimation of presynaptic inhibition.

Authors:  I Milanov
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

7.  Ballistic elbow flexion movements in patients with amyotrophic lateral sclerosis.

Authors:  M Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-03       Impact factor: 10.154

8.  Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity.

Authors:  N Hassan; D L McLellan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-12       Impact factor: 10.154

Review 9.  Consensus Paper: Experimental Neurostimulation of the Cerebellum.

Authors:  Lauren N Miterko; Kenneth B Baker; Jaclyn Beckinghausen; Lynley V Bradnam; Michelle Y Cheng; Jessica Cooperrider; Mahlon R DeLong; Simona V Gornati; Mark Hallett; Detlef H Heck; Freek E Hoebeek; Abbas Z Kouzani; Sheng-Han Kuo; Elan D Louis; Andre Machado; Mario Manto; Alana B McCambridge; Michael A Nitsche; Nordeyn Oulad Ben Taib; Traian Popa; Masaki Tanaka; Dagmar Timmann; Gary K Steinberg; Eric H Wang; Thomas Wichmann; Tao Xie; Roy V Sillitoe
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.